Teva Pharmaceutical Industries Ltd. ADR, TEVA Quick Chart - (NYS) TEVA, Teva Pharmaceutical Industries Ltd. ADR Stock Price - BigCharts.com
Leaner, More Agile Teva Sees Brighter Days Ahead
Israel stocks rise as investors key on Teva, ICL - MarketWatch
Mylan sees opportunity in rival Teva's weakness - MarketWatch
Teva Pharmaceuticals reports earnings on Wednesday. Here's what to expect - MarketWatch
Opinion: These 3 stocks may be the only true value plays left - MarketWatch
Israel stocks up; FTC eyes Teva-Cephalon deal - MarketWatch
U.S. court rules for Teva in migraine patent dispute with Eli Lilly
Teva's stock has tumbled over 8 sessions and Morgan Stanley says it could fall 16% more - MarketWatch
Teva appoints Dipankar Bhattacharjee as Prez, CEO Global Generic Group - The Economic Times
Opinion: Multinationals learn the limits of being big - MarketWatch
Teva releases generic version of Mylan's EpiPen in limited doses in the U.S. - MarketWatch
Teva's stock has tumbled over 8 sessions and Morgan Stanley says it could fall 16% more - MarketWatch
Teva Pharmaceuticals stock falls 11% after earnings miss - MarketWatch
Israel stocks rise, led by Teva, ICL - MarketWatch
Teva stock drops 10% as generics turnaround looks uncertain - MarketWatch
Limor Peleg - Director, Product network & Material Strategy - Teva Pharmaceuticals | LinkedIn
Teva Poised to Get a Big Boost in Generics - WSJ
Teva Pharmaceutical Industries Stock Gives Every Indication Of Being Modestly Undervalued
Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch
Teva to buy Allergan generics for $40.5 billion - MarketWatch
Israel stocks fall for fifth day; Teva rises - MarketWatch
Perrigo rejects Mylan, opening door for Teva - MarketWatch
Three health-care deals today are paying huge premiums - MarketWatch
